fluoxetine has been researched along with phentolamine in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (17.65) | 18.7374 |
| 1990's | 3 (17.65) | 18.2507 |
| 2000's | 5 (29.41) | 29.6817 |
| 2010's | 6 (35.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baldessarini, RJ; Booth, RG; Charifson, PS; Kula, NS; McPhail, AT; Myers, AM; Owens, CE; Wyrick, SD | 1 |
| Bauer, C; Caldwell, L; Kinnier, WJ; Lancaster, J; McMillan, B; Price, CH; Sweetnam, PM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Caliendo, G; Capasso, R; Ciano, A; Corvino, A; Di Vaio, P; Fiorino, F; Frecentese, F; Izzo, AA; Kędzierska, E; Kotlińska, JH; Magli, E; Massarelli, P; Orzelska-Gòrka, J; Perissutti, E; Rossi, I; Saccone, I; Santagada, V; Severino, B | 1 |
| Bryce, GF; Jacoby, JH | 1 |
| Kawasaki, H; Takasaki, K | 1 |
| Martin, LL; Sanders-Bush, E | 1 |
| Fawcett, JP; Menkes, DB; Patel, PP | 1 |
| Dluzen, DE; Shang, Y | 1 |
| James, AN; Parkman, HP; Ryan, JP | 1 |
| Arai, Y; Chancellor, MB; de Groat, WC; Kaiho, Y; Kamo, I; Yoshimura, N | 1 |
| Zargooshi, J | 1 |
2 review(s) available for fluoxetine and phentolamine
| Article | Year |
|---|---|
The role of receptor binding in drug discovery.
Topics: Animals; Drug Design; Humans; Receptors, Drug | 1993 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
15 other study(ies) available for fluoxetine and phentolamine
| Article | Year |
|---|---|
Conformational analysis, pharmacophore identification, and comparative molecular field analysis of ligands for the neuromodulatory sigma 3 receptor.
Topics: Animals; Ligands; Models, Molecular; Molecular Conformation; Receptors, sigma; Rodentia; Structure-Activity Relationship; Tetrahydronaphthalenes | 1994 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
New 5-HT
Topics: Animals; Binding Sites; Biological Assay; Ileum; Ligands; Maze Learning; Molecular Structure; Picolines; Protein Binding; Rats; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Serotonin Receptor Agonists | 2017 |
The acute effects of 5HTP, fluoxetine and quipazine on insulin and glucagon release in the intact rat.
Topics: 5-Hydroxytryptophan; Animals; Blood Glucose; Dose-Response Relationship, Drug; Fluoxetine; Glucagon; Insulin; Insulin Secretion; Male; Methysergide; Phentolamine; Propranolol; Propylamines; Quinolines; Quipazine; Rats | 1979 |
Vasoconstrictor response induced by 5-hydroxytryptamine released from vascular adrenergic nerves by periarterial nerve stimulation.
Topics: Animals; Blood Pressure; Cocaine; Electric Stimulation; Fluoxetine; Hydroxydopamines; Male; Muscle, Smooth, Vascular; Norepinephrine; Oxidopamine; Phentolamine; Rats; Rats, Inbred Strains; Serotonin; Sympathetic Nervous System; Vasoconstriction | 1984 |
The serotonin autoreceptor: antagonism by quipazine.
Topics: Animals; Calcium; Fluoxetine; Hypothalamus; In Vitro Techniques; Male; Methiothepin; Phentolamine; Potassium; Quinolines; Quipazine; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Spiperone | 1982 |
Antidepressant treatment and chemical sympathectomy fail to modulate alpha 1-adrenoceptor sensitivity in mouse eye.
Topics: Administration, Topical; Amitriptyline; Animals; Antidepressive Agents; Benzamides; Desipramine; Down-Regulation; Fluoxetine; Injections, Intraperitoneal; Male; Methoxamine; Mice; Moclobemide; Oxidopamine; Phentolamine; Phenylephrine; Prazosin; Pupil; Receptors, Adrenergic, alpha-1; Sympathectomy, Chemical; Time Factors | 1993 |
Nisoxetine infusion into the olfactory bulb enhances the capacity for male rats to identify conspecifics.
Topics: Adrenergic alpha-Antagonists; Animals; Behavior, Animal; Drug Interactions; Female; Fluoxetine; Hierarchy, Social; Male; Norepinephrine; Olfactory Bulb; Phentolamine; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Recognition, Psychology; Sexual Behavior, Animal; Smell; Social Facilitation | 2001 |
Effects of the selective serotonin reuptake inhibitor, fluoxetine, on regional gastric contractility.
Topics: Adrenergic alpha-Antagonists; Animals; Atropine; Drug Interactions; Fluoxetine; Gastric Fundus; Guinea Pigs; In Vitro Techniques; Indoles; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; Phentolamine; Pylorus; Receptors, Neurotransmitter; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Stomach; Sulfonamides; Tetrodotoxin | 2005 |
Role of noradrenergic pathways in sneeze-induced urethral continence reflex in rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Animals; Female; Fluoxetine; Norepinephrine; Phentolamine; Prazosin; Pressure; Rats; Rats, Sprague-Dawley; Sneezing; Urethra; Urinary Incontinence, Stress; Vagina | 2007 |
Male sexual dysfunction in unconsummated marriage: long-term outcome in 417 patients.
Topics: Adolescent; Adult; Aged; Clomipramine; Erectile Dysfunction; Female; Fluoxetine; Follow-Up Studies; Humans; Iran; Male; Marriage; Middle Aged; Papaverine; Phentolamine; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Sex Education; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Social Values; Young Adult | 2008 |